Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced it has entered into a securities purchase agreement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE